Since the short-chain fatty acids (SCFAs) are released by the gut microbiome, the alteration of microbiome composition in obesity and T2DM disrupts SCFA production and affects insulin sensitivity and energy metabolism. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.